drugset / Trial / NCT01301261

Sugammadex: Effect on the Awareness Monitoring and Hemodynamics

NCT01301261

Unknown 60 enrolled University of Athens
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Sugammadex is used to reverse the neuromuscular blocking effect of steroid neuromuscular blockers. Its cardiovascular effects and effect on brain cortex, if any, may be associated to the reversal of the neuromuscular block. The aim of the study was to investigate the pure effects of sugammadex in the absence of the agonist.

Timeline

Start
2010-12
Primary completion
2013-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sugammadex Other / unclassified 2 mg/kg
Comparator Sugammadex Other / unclassified 4 mg/kg
Comparator Sugammadex Other / unclassified 16 mg/kg

Indications

No indication recorded.